相关实验视频
Updated: Jan 9, 2026

06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
5.9K
脱化酶Cezanne通过抵消APC/C和Ube2S依赖的Lys11相关的泛化来稳定BRCA1
Longqiang Wang1, Xiao Wu1, Atanu Paul1,2
1Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
PLoS biology
|December 8, 2025
概括
研究人员发现了一种通过ubiquitin K11-linkage修饰来控制BRCA1蛋白稳定的新途径. 这一发现揭示了通过PARPi疗法准BRCA1缺陷瘤的机制.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- BRCA1 是乳腺癌和卵巢癌的关键瘤抑制剂.
- 瘤中的BRCA1水平降低可以模仿BRCA1突变特征,并预测对PARP抑制剂 (PARPi) 治疗的反应.
- 了解BRCA1调节是开发向癌症治疗的关键.
研究的目的:
- 阐明调节BRCA1蛋白稳定性的机制.
- 为了确定在BRCA1调节中无处不在的作用.
- 探索向癌症中的BRCA1稳定性的治疗影响.
主要方法:
- 通过细胞周期分析研究了BRCA1蛋白的稳定性.
- 利用无处不在的测试来识别BRCA1.1的K11结合修饰.
- 研究了Cezanne,APC/C和Ube2S在BRCA1调节中的作用.
- 分析瘤表达和突变数据以与患者预后相关.
主要成果:
- 通过ubiquitin K11-linkage确定了一种新型细胞周期依赖的途径,通过ubiquitin K11-linkage控制BRCA1稳定性.
- 证明了塞尚的二氧化酶调节了BRCA1 K11-二氧化.
- 表明塞桑尼缺陷降低了BRCA1水平,并增加了对PARPi的敏感性.
- 发现低Cezanne或高Ube2S表达与"BRCAness"和乳腺癌的不良预后相关.
结论:
- 一个与ubiquitin K11相关的ubiquitination通路调节了BRCA1蛋白质的稳定性.
- 这种途径的失调导致BRCA1缺乏,这是PARPi治疗的潜在生物标志物.
- 这一途径为治疗缺乏BRCA1的癌症提供了新的标.
相关概念视频
Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Regulated Protein Degradation
3.0K
3.0K
Nucleotide Excision Repair
40.5K
Overview
40.5K
Nucleotide Excision Repair
4.9K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
4.9K
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K

